WIF1 and lung carcinoma: Rather, aberrant Wnt activity in lung cancer is linked to increased expression of upstream Wnt signaling effectors such as Dvl [17] or decreased expression of Wnt antagonists such as Wnt-inhibitory factor 1 (Wif-1) [18,19].